Axogen (AXGN) Other financing activities (2011 - 2026)
Axogen's (AXGN) quarterly Other financing activities came in at $4.2 million in Q1 2026, up 77.34% year-on-year from $2.4 million in Q1 2025, and down 7.87% quarter-over-quarter from $4.6 million in Q4 2025.
Axogen (AXGN) Other financing activities (2011 - 2026) Analysis & Trends
Axogen's Other financing activities history runs 16 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- On a quarterly basis, Other financing activities rose 77.34% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 176.45% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 357.87% from the prior year.
- Other financing activities retreated to $4.2 million in Q1 2026 per AXGN's latest filing, from $4.6 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.6 million in Q4 2025 and bottomed at $97000.0 in Q1 2022.
- The 5-year median for Other financing activities is $743000.0 (2022), against an average of $1.3 million.
- Across the five-year window, Other financing activities plunged 81.38% in 2022 and surged 1051.21% in 2025, its largest moves.
- Year by year, Other financing activities stood at $816000.0 in 2022, then slumped by 48.41% to $421000.0 in 2023, then jumped by 131.35% to $974000.0 in 2024, then surged by 370.94% to $4.6 million in 2025, then fell by 7.87% to $4.2 million in 2026.
- Per Business Quant, the three latest AXGN Other financing activities figures stand at $4.2 million (Q1 2026), $4.6 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 974,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Mar 31, 2024 | 207,000.00 |
| Mar 31, 2024 | 207,000.00 |
| Dec 31, 2023 | 421,000.00 |
| Dec 31, 2023 | 421,000.00 |